Data from EMC - Curated by Toby Galbraith - Last updated 14 March 2017

Licensing authority

MHRA (Medicines and Healthcare products Regulatory Agency, UK)

Indication(s)

Actikerall is indicated for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (grade I/II) in immunocompetent adult patients.

Grade I/II intensity is based on the 4-point scale of Olsen et al. (1991).

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone


Bedwetting

Essential screening, diagnosis and best strategies to manage bedwetting

Visit Bedwetting


Related Content

More information

Category Value
Authorisation number PL 33016/0015
Orphan designation No
Date First Approved 03-06-2011
Type POM
Marketing authorisation holder Almirall Hermal GmbH